In-house Pipeline
Designing success; we've turned ideas into reality. Dive into the stories of designer drugs that make a difference.
Our pipeline is the result of in-house drug development across various stages, covering the target identification and preclinical stage, demonstrating advanced AI and robotics capabilities
Target
Therapeutic Area
Progress
Ln-101
Muscular Atrophy, Trauma Recovery, Sarcopenia
Ln-202
Chemical Threat, Opioid Overdose Prophylaxis
Ln-303
Appetite Regulation, Obesity
Our Story